89810-- Rapid Equilibrium Dialysis (RED) Device
- 公司名稱 北京華夏遠洋科技有限公司
- 品牌 Thermofisher Scientific/賽默飛世爾
- 型號 89810--
- 產(chǎn)地 Thermo pierce
- 廠商性質(zhì) 代理商
- 更新時間 2017/8/16 16:01:05
- 訪問次數(shù) 3000
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
Genscript(北京一級代理),USCN(北京一級代理),Qiagen、Toyobo、Sigma、Amresco、Roche、Santa cruz、Fermantas、Abcam、Invitrogen、GE、CST、R&D systems、Omega、Biomiga、Biovision、Merck、Corning、Axygen、NUNC、BD、Thermo、Millipore、碧云天、南京建成、杭州愛思進、LetPub專業(yè)SCI論文編輯北京辦事處、技術(shù)服務(wù)項目。
Rapid Equilibrium Dialysis (RED) Device
The Thermo Scientific Pierce RED Device for Rapid Equilibrium Dialysis was developed in close association with the pharmaceutical industry to provide the easiest, fastest and most reliable system for performing plasma protein-binding assays, which comprise a critical step in drug development.
- Easy and ready to use – disposable tubes require no presoaking, assembly or specialized equipment
- Designed for speed – the high surface-to-volume ratio of the insert design enables equilibrium to be reached in as few as 100 minutes with vigorous agitation or in three to four hours with 200rpm agitation
- Automation-compatible – designed on a standard 96-well plate template suitable for automated liquid handlers
- Flexible and scalable – perform any number of assays (1 to 48 assays per plate) without wasting the entire plate
- Robust – compartmentalized design eliminates potential for cross talk or leakage
- Reproducible and accurate – validated for plasma binding assays, producing results consistent with those reported in literature
- Quality-tested – each lot of inserts is functionally tested in a protein-binding assay for guaranteed performance
- Disposable: require no presoaking, assembly, or specialized equipment
- Short incubation time: large dialysis surface area accelerates equilibrium
- 8K MWCO membrane: ideal molecular-weight cutoff for protein-drug binding studies
- 12K or 25K MWCO membranes are also available as a custom order (minimum order, 10 plates) for larger drug molecules retained by the standard 8K MWCO
- Membrane composition: regenerated cellulose with low glycerol content as a humectant
- Microplate footprint: compatible with automated systems for 96-well plates
- Compartmentalized: eliminates potential for crosstalk or leakage
- PTFE construction: eliminates nonspecific binding and risk of contamination
- Accepts 1 to 48 inserts: run exactly the number of assays needed without waste
- Determination of free vs. drug bound to plasma proteins
- Pharmacokinetics studies
- Formulation of drug dosage for in vivo studies
- Drug-drug interaction studies
- Selection criteria during drug lead optimization
- Drug partition between plasma and whole blood
- Solubility study
- Dissociation constant determination (Kd)
- Tissue-binding study using tissue homogenate
![]() | Use the RED Device for increased productivity. Each RED Device Base Plate sits in a 96-well plate footprint withe 9 x 9 mm well spacing making it compatible with automated liquid handling systems. Single-Use RED Base Plates are available with inserts preloaded mimimizing setup time. Rapid Equilibrium Dialysis Device Frequently Asked Questions. Please click here to see the Rapid Equilibrium Device Demonstration Video. |
The RED Device reproduces results found in the literature. Performance of pre-loaded Single-Use RED Device Base Plates (Product # 90006) using high, medium and low protein-binding compounds tested at 1 mM on human plasma. | ||
Human plasma (% bound) | ||
Compound | RED plate | *Other Device |
Warfarin | 99.24 | 99 |
Taxol | 96.16 | 95 to 98 |
Propanolol | 91.81 | 80 to 92 |
Vinblastine | 99.30 | 99 |
Verapamil | 90.31 | 88 to 92 |
Atenolol | 3.50 | < 5 |
Antipyrine | 0 | 0 |
*Values reported in the literature.2-6 |
The RED Device for comparison of plasma and microsome samples. Comparison of protein bindings between human plasma and human microsome at 1 mM concentration as determined using the Single-Use RED Device. | ||
Compound | Human Plasma, % free | Human Microsome, % free |
Warfarin | < 1 | 81 |
Taxol | 4 | 20 |
Propanolol | 8 | 44 |
Vinblastine | 0.7 | 4 |
Verapamil | 10 | 27 |
Methotrexate | 50 | 70 |
Simvastatin | 7 | 23 |
Atenolol | 97 | 100 |
Antipyrine | 100 | 100 |
*Microsomal protein concentration of 1.0 mg/ml is used in the study |
The RED Device had many advantages to other methods. The RED Device System offers significant improvements in the ease of use, time requirements, versatility and product reliability compared to other methods. | |||||
Device | Time to reach Equilibrium | Disposable | Labor Intensity | Automation Accessible | Vol. Shift |
RED (Rapid Equilibrium Dialysis), (Pierce) | 4 Hr | Yes | + | Yes | None |
96 - well Micro Equilibrium Dialysis block (HTDDialysis, LLC) | 6 Hr | No | +++ | Possible | Yes |
24-Multiwell Dialysis (BD Biosciences) | 24 Hr | Yes | ++ | Possible | Not measured |
Shelley Li1, Bob Xiong2, Tainang Huang2, Lily Li2, John Donovan3, Frank Lee*1, Shaoxia Yu1, Gerald Miwa1, Hua Yang*1 1DMPK/Drug Safety & Disposition, and 3Process Technology, Millennium Pharmaceuticals, Inc. 40 Landsdowne Street, Cambridge, MA 02139 USA and 2Linden Bioscience, 35A Cabot Road, Woburn, MA 01801, USA Equilibrium can be reached in as little as 100 minutes with mild agitation or 3-4 hours with no agitation. |
Posters: Download a PDF version of the following posters.
Susan Chen, Ji Zhang, Tai-Nang Huang1, Jing-Tao Wu, Frank W. Lee, and Mark G. Qian DMPK,
1 DMPK/Drug Safety & Disposition, and Process Technology, Millennium Pharmaceuticals, Inc. 40 Landsdowne Street, Cambridge, MA 02139 USA
2 Linden Bioscience, 35A Cabot Road, Woburn, MA 01801, USA
Mark G. Qian, Tai-Nang Huang1, Susan Chen, Ji Zhang, Cindy Xia, Chuang Lu, Jing-Tao Wu, and Frank W. Lee
Millennium Pharmaceuticals, Inc. 40 Landsdowne Street, Cambridge, MA 02139 USA
2 Linden Bioscience, 35A Cabot Road, Woburn, MA 01801, USA
Steve Harris, Jonathan Duckworth, Katie Critchell, Charlie Malloy, Christine Tyman and Mark Savage. Pfizer Pharmacokinetics, Dynamics and Metabolism Department, PGRD, Sandwich, Kent , UK
by Kevin L. Cook, Dennis M. Kalamaridis, Jose Silva, Jie Chen, Carlo Sensenhauser, Vangala Subrahmanyam, and H. K. Lim DMPK, GPCD, Johnson & Johnson PRD, Raritan, NJ
Rachel Jones, Bindi Sohal, Nigel Waters, Gareth Williams
Metabolism & Pharmacokinetics, Novartis Institutes for Biomedical Research, Horsham, UK
- Waters, N.J., et al. (2008). Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J Pharm Sci 97(10): 4586-95.
- Brouwer, E.J., et al. (2000). Measurement of fraction unbound paclitaxel in human plasma. Drug Metab Disposition 28(10): 1141-5.
- Brunton, L., et al. Goodman and Gilman's Pharmacological Basis of Therapeutics. McGraw Hill Publishing: New York, 2005.
- Clausen, J. and Bickel, M. (1993). Prediction of drug distribution in distribution dialysis and in vivo from binding to tissue and blood. J Pharm Sci 82: 345-9.
- Sonnichsen, D. and Relling, M. (1994). Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet 27: 256-69.
- Steele, W., et al. (1983). The protein binding of vinblastrine in the serum of normal subjects and patients with Hodgkin's disease. Eur J Clin Pharmacol 24: 683-7.
New Competition Rapid Equilibrium Dialysis (RED) Products and Accessories
Pierce Protein Precipitation Plates
Sealing Tape for Microplates
Phosphate Buffered Saline
LC/MS Grade Acetonitrile
Trifluoroacetic Acid
Ordering Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
相關(guān)分類
該廠商的其他產(chǎn)品
- 89888-- Pierce SDS-PAGE Sample Prep Kit
- 89802-- I-PER Insect Cell Protein Extraction Reagent
- 20148-- LightShift Chemiluminescent EMSA Kit
- 90084-- B-PER Protein Extraction Reagents
- 89826-- Mem-PER Eukaryotic Membrane Protein Extraction Kit
- 89818-- DNA 3' End Biotinylation Kit
- 78833-- NE-PER Nuclear and Cytoplasmic Extraction Reagents
- 78501-- M-PER Mammalian Protein Extraction Reagent